FDA Panel Discusses Improving Risk Communications

Drug Industry Daily
A A
How to improve the FDA’s ability to communicate accurate risk information about drugs, devices and food to the public was the subject of a meeting of the Risk Communication Advisory Committee.

To View This Article:

Login

Subscribe To Drug Industry Daily